Literature DB >> 11694864

[Indication of CGMS (Continuous Glucose Monitoring System) in the functionnal investigations of adult type 1 diabetic patients].

V Melki1, H Hanaire-Broutin.   

Abstract

The Minimed CGMS (Continuous Glucose Monitoring System) is a holter-style electroenzymatic sensor allowing 3-days continuous monitoring of interstitial glucose fluctuations. This device gathers wide informations about the fluctuations of glucose over the day, in a more detailed (288 measurements) but less accurate way than those obtained from glucose self-monitoring. Its utilisation has been proposed for the analysis of nocturnal glucose control, to detect asymptomatic hypoglycemia or dawn phenomenon, and could be useful in the adjustment of type 1 diabetes therapy. Thus, its use could contribute to an improvement in glucose control, especially in patients with low compliance to self-monitoring. CGMS graphs can be used as an individual teaching support, or illustrate characteristic situations during collective educational sessions. The period chosen for the CGMS record, the duration of the record and the instructions given to the patients are of major importance to obtain accurate and reproductive graphs, that can be used in clinical practice.

Entities:  

Mesh:

Year:  2001        PMID: 11694864

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  1 in total

1.  Correlations of glucose levels in interstitial fluid estimated by continuous glucose monitoring systems and venous plasma.

Authors:  Byung-Joon Kim
Journal:  Korean Diabetes J       Date:  2010-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.